This bill, titled the "Lower Health Care Premiums for All Americans Act," seeks to improve access to affordable health insurance by expanding health care options for workers and increasing transparency in prescription drug pricing. It introduces significant changes to how group health plans operate and how pharmacy benefit managers disclose financial information, alongside provisions for funding cost-sharing reductions.

Title I of the bill focuses on improving health care options for workers. It amends the Employee Retirement Income Security Act of 1974 (ERISA) to expand the availability of Association Health Plans (AHPs), allowing groups of employers to form such plans even if they are not in the same industry. These AHPs must be formed for purposes other than just providing health coverage, have a formal governing structure, and have existed for at least two years before offering a plan. They are required to offer coverage to at least 51 employees and all employees of member employers, and cannot discriminate based on health status or deny coverage for pre-existing conditions.

The bill also clarifies that AHPs may establish base premium rates using an actuarially sound, modified community rating methodology, and can adjust individual employer contribution rates based on their specific risk profiles, where state law permits. For groups composed solely of self-employed individuals, all participants must be treated as a single risk pool and charged the same premium rate. Furthermore, the legislation clarifies that medical stop-loss insurance for self-insured plans is not considered health insurance coverage and preempts state laws that might hinder plans from insuring against excess claims.

Another key provision in Title I addresses Health Reimbursement Arrangements (HRAs), specifically "custom health option and individual care expense arrangements" (CHOICE arrangements). These employer-funded HRAs, which reimburse medical care for individuals covered by individual health insurance or Medicare, are deemed to meet certain Affordable Care Act (ACA) requirements. The bill outlines nondiscrimination rules for offering these arrangements to specified employee classes and allows participants to purchase exchange insurance through cafeteria plans, with these benefits to be reported on W-2 forms starting in 2026.

Title II focuses on lowering health care premiums, primarily through enhanced oversight of Pharmacy Benefit Management (PBM) services. It mandates that PBMs and related entities provide comprehensive, semi-annual reports to group health plans and health insurance issuers. These reports must disclose detailed information on drug pricing, including contracted compensation, the difference between payments to pharmacies and payments from plans, and the net price after rebates and other remuneration.

The required PBM reports also include data on therapeutic drug classes, high-spending drugs, and financial arrangements with affiliated pharmacies. This includes gross and net spending, rebates received by both the plan/issuer and the PBM, and out-of-pocket spending by participants. The bill imposes significant civil monetary penalties for non-compliance or for knowingly providing false information, with the Secretaries of Health and Human Services, Labor, and the Treasury tasked with establishing standard reporting formats and regulations.

Finally, Title II addresses the funding of cost-sharing reduction (CSR) payments under the ACA. It permanently appropriates necessary sums from the Treasury for these payments for plan years beginning on or after January 1, 2027. However, it explicitly prohibits the use of these funds for qualified health plans that cover abortion, except in cases necessary to save the life of the mother or when the pregnancy results from rape or incest.